BACKGROUND: Controversial reports on prolactin receptors (PRL-R), the long and short form, on endothelial cells (EC) may be explained by the choice of EC derived from the micro- and macrovascular bed of either endocrine and non-endocrine organs. METHODS: We studied here PRL-R expression in organs [bovine corpus luteum (CL), umbilical vein, aorta] and in organ-derived EC cultures. RESULTS: In the intact CL, both PRL-R forms were present at mRNA and protein level throughout the oestrous cycle stages. The short form prevailed as protein. PRL-R-positive EC were noted by immunofluorescent staining in arterial blood vessels of CL septa, in the umbilical vein and the aorta. In EC cultures of micro- and macrovascular origin, transcripts of both PRL-R forms were shown; again the short-form protein prevailed. Blocking experiments with anti-prolactin (PRL) antibody led to a 60% decrease in cell growth. Treatment with PRL had no effect. CONCLUSION: PRL-R expression in micro- and macrovascular EC is associated with the predominant short form. Copyright (c) 2007 S. Karger AG, Basel.
BACKGROUND: Controversial reports on prolactin receptors (PRL-R), the long and short form, on endothelial cells (EC) may be explained by the choice of EC derived from the micro- and macrovascular bed of either endocrine and non-endocrine organs. METHODS: We studied here PRL-R expression in organs [bovine corpus luteum (CL), umbilical vein, aorta] and in organ-derived EC cultures. RESULTS: In the intact CL, both PRL-R forms were present at mRNA and protein level throughout the oestrous cycle stages. The short form prevailed as protein. PRL-R-positive EC were noted by immunofluorescent staining in arterial blood vessels of CL septa, in the umbilical vein and the aorta. In EC cultures of micro- and macrovascular origin, transcripts of both PRL-R forms were shown; again the short-form protein prevailed. Blocking experiments with anti-prolactin (PRL) antibody led to a 60% decrease in cell growth. Treatment with PRL had no effect. CONCLUSION:PRL-R expression in micro- and macrovascular EC is associated with the predominant short form. Copyright (c) 2007 S. Karger AG, Basel.
Authors: Carmen Gonzalez; Hector Rosas-Hernandez; Brenda Jurado-Manzano; Manuel Alejandro Ramirez-Lee; Samuel Salazar-Garcia; Pedro Pablo Martinez-Cuevas; Aída Jimena Velarde-Salcedo; Humberto Morales-Loredo; Ricardo Espinosa-Tanguma; Syed F Ali; Rafael Rubio Journal: Acta Pharmacol Sin Date: 2015-04-20 Impact factor: 6.150
Authors: Carmen Clapp; Norma Adán; María G Ledesma-Colunga; Mariana Solís-Gutiérrez; Jakob Triebel; Gonzalo Martínez de la Escalera Journal: Cell Mol Life Sci Date: 2016-03-29 Impact factor: 9.261
Authors: Anne Q Reuwer; Brigitte M Sondermeijer; Suzanne Battjes; Rogier van Zijderveld; Danka J F Stuijver; Peter H Bisschop; Marcel Th B Twickler; Joost C M Meijers; Reinier O Schlingemann; Erik S Stroes Journal: Pituitary Date: 2012-12 Impact factor: 4.107
Authors: Anne Q Reuwer; Patrycja Nowak-Sliwinska; Laurie A Mans; Chris M van der Loos; Jan H von der Thüsen; Marcel Th B Twickler; C Arnold Spek; Vincent Goffin; Arjan W Griffioen; Keren S Borensztajn Journal: J Cell Mol Med Date: 2012-09 Impact factor: 5.310